Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis

Despite recent therapeutic advances, systemic mastocytosis (SM) remains an incurable disease due to limited complete remission (CR) rates even after novel therapies. To date, no study has evaluated the expression on SM bone marrow mast cells (BMMC) of large panel of cell surface suitable for antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Dasilva-Freire, Noelia, Mayado, Andrea, Teodosio, Cristina, Jara-Acevedo, María, Álvarez-Twose, Iván, Matito, Almudena, Sánchez-Muñoz, Laura, Caldas, Carolina, Henriques, Ana, Muñoz-González, Javier I., García-Montero, Andrés C., Sánchez-Gallego, J. Ignacio, Escribano, Luis, Orfao, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387409/
https://www.ncbi.nlm.nih.gov/pubmed/30696068
http://dx.doi.org/10.3390/ijms20030552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387409/
https://www.ncbi.nlm.nih.gov/pubmed/30696068
http://dx.doi.org/10.3390/ijms20030552

Ejemplares similares